InMed Pharmaceuticals (INM) Amortizatization of Intangibles (2022 - 2026)

InMed Pharmaceuticals has reported Amortizatization of Intangibles for 5 years, with the latest figure at $82949.0 in Q1 2026.

• For the quarter ending Q1 2026, Amortizatization of Intangibles rose 7.34% year-over-year to $82949.0; the trailing twelve-month figure through Mar 2026 stood at $369575.0 (up 8.49% YoY), and the FY2025 full-year result was $321885.0, down 16.38% from the prior year.
• Amortizatization of Intangibles for Q1 2026 stood at $82949.0, down from $104818.0 in the prior quarter.
• The five-year high for Amortizatization of Intangibles was $104818.0 in Q4 2025, with the low at $75876.0 in Q4 2024.
• Historically, Amortizatization of Intangibles has averaged $91516.6 across 5 years, with a median of $93085.0 in 2023.
• The largest YoY upside for Amortizatization of Intangibles was 38.14% in 2025 against a maximum downside of 19.33% in 2025.
• InMed Pharmaceuticals' Amortizatization of Intangibles stood at $90389.0 in 2022, then grew by 2.98% to $93085.0 in 2023, then dropped by 18.49% to $75876.0 in 2024, then soared by 38.14% to $104818.0 in 2025, then declined by 20.86% to $82949.0 in 2026.
• The last three Amortizatization of Intangibles figures came in at $82949.0 (Q1 2026), $104818.0 (Q4 2025), and $103478.0 (Q3 2025), per Business Quant data.